Form 4: Clearfield CEO Cheryl Beranek Executes Stock Sale

Clearfield, Inc. CEO Cheryl Beranek sold 7,500 shares of common stock pursuant to a pre-established Rule 10b5-1 trading plan.

Summary

• CEO Cheryl Beranek sold 7,500 shares of Clearfield, Inc. (CLFD) common stock.
• The sale occurred on June 1, 2026, at a weighted average price of $46.92 per share.
• The transaction was executed under a Rule 10b5-1 trading plan adopted on December 15, 2025.
• Following the transaction, the CEO retains beneficial ownership of 494,541 shares.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event, as the sale was pre-planned and represents a small portion of the CEO's total holdings.

Positives

• The sale was conducted via a pre-planned Rule 10b5-1 trading plan, which is a standard mechanism for executives to sell stock without triggering insider trading concerns.

Negatives

• The sale represents a reduction in the CEO's direct equity stake in the company.

Risks

• Insider selling can sometimes be perceived negatively by the market as a signal regarding the executive's outlook on future stock performance.

Future Outlook

No specific forward-looking guidance regarding company operations was provided in this filing.

Industry Context

StockSavvy.ai notes that executive stock sales under 10b5-1 plans are routine corporate governance events and generally do not reflect a change in fundamental business strategy or performance.

Comparison to Industry Standards

• The use of Rule 10b5-1 plans is the industry standard for executives to manage personal liquidity while maintaining compliance with SEC regulations.

Stakeholder Impact

• Minimal impact expected as the sale was executed through a pre-arranged plan.

Next Steps

• Continued monitoring of future Form 4 filings for further insider activity.

Key Dates

Keywords

Clearfield, CLFD, Insider Trading, Form 4, Cheryl Beranek, Stock Sale